Tymlos 3.12 mg/1.56mL
abaloparatide · INJECTION, SOLUTION · Radius Health, Inc.
No Recall History
Plain English
Tymlos is a injection, solution containing abaloparatide at 3.12 mg/1.56mL, taken subcutaneous. Manufactured by Radius Health, Inc..
Key Facts
- Brand Name
- Tymlos
- Generic Name
- abaloparatide
- NDC Code (Product)
70539-001- Manufacturer
- Radius Health, Inc.
- Strength
- 3.12 mg/1.56mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA208743
- Drug Class
- Parathyroid Hormone-Related Peptide Analog [EPC]
- Marketing Start
- 05/01/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Tymlos used for?
Tymlos contains abaloparatide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Tymlos a controlled substance?
Tymlos is not classified as a controlled substance by the DEA.
What is the generic name for Tymlos?
The generic name for Tymlos is abaloparatide. There are no other listed brand versions of abaloparatide.
What is the NDC code for Tymlos 3.12 mg/1.56mL?
The NDC (National Drug Code) for Tymlos 3.12 mg/1.56mL is 70539-001, listed by Radius Health, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)